PMC:7035340 / 523-793 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"23","span":{"begin":75,"end":83},"obj":"Species"},{"id":"31","span":{"begin":89,"end":108},"obj":"Disease"},{"id":"32","span":{"begin":211,"end":246},"obj":"Disease"},{"id":"33","span":{"begin":248,"end":252},"obj":"Disease"},{"id":"34","span":{"begin":257,"end":269},"obj":"Disease"}],"attributes":[{"id":"A23","pred":"tao:has_database_id","subj":"23","obj":"Tax:9606"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"MESH:C000657245"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"MESH:D012128"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"MESH:D012128"},{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"MESH:D012772"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, according to the Chinese government’s daily report, 13.2–21.3% of patients with 2019-nCoV infection developed into severe or fatal illness (Fig. S1a), which is characterized by the rapid development to acute respiratory distress syndrome (ARDS) or septic shock."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T5","span":{"begin":89,"end":108},"obj":"Disease"},{"id":"T6","span":{"begin":99,"end":108},"obj":"Disease"},{"id":"T7","span":{"begin":211,"end":246},"obj":"Disease"},{"id":"T8","span":{"begin":217,"end":246},"obj":"Disease"},{"id":"T9","span":{"begin":248,"end":252},"obj":"Disease"}],"attributes":[{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0009971"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"}],"text":"However, according to the Chinese government’s daily report, 13.2–21.3% of patients with 2019-nCoV infection developed into severe or fatal illness (Fig. S1a), which is characterized by the rapid development to acute respiratory distress syndrome (ARDS) or septic shock."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":217,"end":237},"obj":"Phenotype"},{"id":"T3","span":{"begin":264,"end":269},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0002098"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0031273"}],"text":"However, according to the Chinese government’s daily report, 13.2–21.3% of patients with 2019-nCoV infection developed into severe or fatal illness (Fig. S1a), which is characterized by the rapid development to acute respiratory distress syndrome (ARDS) or septic shock."}

{"project":"LitCovid-sentences","denotations":[{"id":"T6","span":{"begin":0,"end":270},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, according to the Chinese government’s daily report, 13.2–21.3% of patients with 2019-nCoV infection developed into severe or fatal illness (Fig. S1a), which is characterized by the rapid development to acute respiratory distress syndrome (ARDS) or septic shock."}